List of Monash University patents

Patents where

Current Assignee

Name

Monash University

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11446393 Non-viral gene delivery agent comprising lipopeptide (LP) compounds		Monash University	Monash University	United States Patent and Trademark Office	11446393	September 20, 2022
‌ US Patent 11306066 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors			Monash University	United States Patent and Trademark Office	11306066	April 19, 2022
‌ US Patent 11391746 Testing device for identifying antigens and antibodies in biofluids	Patent 11391746 was granted and assigned to Monash University on July, 2022 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	11391746	July 19, 2022
‌ US Patent 8748582 Affinity ligands and methods for protein purification	Patent 8748582 was granted and assigned to Monash University on June, 2014 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	8748582	June 10, 2014
‌ US Patent 9376372 Process for producing amine compounds	Patent 9376372 was granted and assigned to Monash University on June, 2016 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	9376372	June 28, 2016
‌ US Patent 10294280 Constrained proteins and uses therefor	Patent 10294280 was granted and assigned to Monash University on May, 2019 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	10294280	May 21, 2019
‌ US Patent 10267675 Multi-directional optical receiver	Patent 10267675 was granted and assigned to Monash University on April, 2019 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	10267675	April 23, 2019
‌ US Patent 10077301 IL-21 binding proteins	Patent 10077301 was granted and assigned to Monash University on September, 2018 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	10077301	September 18, 2018
‌ US Patent 9751763 Material and applications therefor	Patent 9751763 was granted and assigned to Monash University on September, 2017 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	9751763	September 5, 2017
‌ US Patent 10894944 Cell culture media	Patent 10894944 was granted and assigned to Monash University on January, 2021 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	10894944	January 19, 2021
‌ US Patent 10806770 Powder formulation	Patent 10806770 was granted and assigned to Monash University on October, 2020 by the United States Patent and Trademark Office.	GlaxoSmithKline	Monash University	United States Patent and Trademark Office	10806770	October 20, 2020
‌ US Patent 11137390 Liquid distribution and diagnostic device and system	Patent 11137390 was granted and assigned to Monash University on October, 2021 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	11137390	October 5, 2021
‌ US Patent 10368770 Neural event process	Patent 10368770 was granted and assigned to Monash University on August, 2019 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	10368770	August 6, 2019
‌ US Patent 7012142 Process for preparation of bicyclic and polycyclic molecules	Patent 7012142 was granted and assigned to Monash University on March, 2006 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	7012142	March 14, 2006
‌ US Patent D1003426 Inhaler	Patent D1003426 was granted and assigned to Monash University on October, 2023 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	D1003426	October 31, 2023
‌ US Patent 11834663 Fibrotic treatment	Patent 11834663 was granted and assigned to Monash University on December, 2023 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	11834663	December 5, 2023
‌ US Patent 11878165 Transcranial stimulation with real-time monitoring	Patent 11878165 was granted and assigned to Monash University on January, 2024 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	11878165	January 23, 2024
‌ US Patent 11746396 High strength aluminium alloy for rapid solidification manufacturing processes	Patent 11746396 was granted and assigned to Monash University on September, 2023 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	11746396	September 5, 2023
‌ US Patent 6881740 Pharmaceutical agents	Patent 6881740 was granted and assigned to Monash University on April, 2005 by the United States Patent and Trademark Office.		Monash University	United States Patent and Trademark Office	6881740	April 19, 2005
‌ US Patent 11976343 High strength aluminium alloy for rapid solidification manufacturing processes	Patent 11976343 was granted and assigned to Monash University on May, 2024 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	11976343	May 7, 2024
‌ US Patent D1019932 Inhaler	Patent D1019932 was granted and assigned to Monash University on March, 2024 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	D1019932	March 26, 2024
‌ US Patent 12060581 Methods and cellular structures	Patent 12060581 was granted and assigned to Monash University on August, 2024 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	12060581	August 13, 2024
‌ US Patent 11752116 Method of viral inhibition	Patent 11752116 was granted and assigned to Monash University on September, 2023 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	11752116	September 12, 2023
‌ US Patent 11780915 Binding proteins to the human thrombin receptor, PAR4	Patent 11780915 was granted and assigned to Monash University on October, 2023 by the United States Patent and Trademark Office.	Monash University	Monash University	United States Patent and Trademark Office	11780915	October 10, 2023

24 results

0 selected

24 results

0 selected